U.S. markets open in 6 hours 55 minutes
  • S&P Futures

    4,539.25
    -32.00 (-0.70%)
     
  • Dow Futures

    35,041.00
    -218.00 (-0.62%)
     
  • Nasdaq Futures

    15,073.50
    -132.50 (-0.87%)
     
  • Russell 2000 Futures

    2,073.80
    -18.30 (-0.87%)
     
  • Crude Oil

    86.09
    +0.66 (+0.77%)
     
  • Gold

    1,812.30
    -0.10 (-0.01%)
     
  • Silver

    23.60
    +0.11 (+0.48%)
     
  • EUR/USD

    1.1343
    +0.0013 (+0.11%)
     
  • 10-Yr Bond

    1.8650
    0.0000 (0.00%)
     
  • Vix

    22.79
    +3.60 (+18.76%)
     
  • GBP/USD

    1.3604
    +0.0005 (+0.04%)
     
  • USD/JPY

    114.3600
    -0.2250 (-0.20%)
     
  • BTC-USD

    41,366.64
    -676.59 (-1.61%)
     
  • CMC Crypto 200

    1,173.34
    +163.96 (+16.24%)
     
  • FTSE 100

    7,563.55
    -47.68 (-0.63%)
     
  • Nikkei 225

    27,467.23
    -790.02 (-2.80%)
     

Guardion Health Sciences to Present at the LD Micro Virtual Invitational Conference on June 9, 2021

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

SAN DIEGO, June 02, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI), a clinical nutrition and diagnostics company that develops clinically supported nutrition, supplements, medical foods, and medical devices, announced today that Chief Executive Officer Bret Scholtes will present a corporate overview at the three-day LD Micro Virtual Invitational Conference being held on June 8 – 10, 2021.

Mr. Scholtes will deliver his corporate presentation on June 9 at 12:30pm ET, Track 2.

Investors can register to watch the presentation here.

Investors interested in scheduling a meeting with management should contact assistant@ldmicro.com.

About Guardion Health Sciences, Inc.

Guardion Health Sciences, Inc. (NASDAQ: GHSI), is a clinical nutrition and diagnostics company. Guardion offers a portfolio of science-based, clinically supported nutrition, supplements, medical foods, and diagnostic products that support healthcare professionals, their patients, and consumers in achieving health goals. Guardion’s commercial and developmental initiatives are supported by equally impressive scientific and medical advisory boards, led by seasoned business executives and physicians with many years of experience. This combination of expertise and scientific knowledge forms the foundation of Guardion’s growing position within the eye care industry and the clinical nutrition marketplace. Information and risk factors with respect to Guardion and its business, including its ability to successfully develop and commercialize its proprietary products and technologies, may be obtained in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”) at www.sec.gov.

Investor Relations Contact:
CORE IR
Scott Arnold
516-222-2560
scotta@coreir.com

Media Relations Contact:
Jules Abraham
Director of Public Relations
CORE IR
917-885-7378
julesa@coreir.com